Image

    Effects of Oral Contraceptives Containing Desogestrel and Drospirenone on Clinical, Hormonal, and Metabolic Parameters of Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial

    Mina Amiri, Fahimeh Ramezani Tehrani, Razieh Bidhendi Yarandi, Fatemeh Nahidi
    Studysummary This randomized clinical trial found that oral contraceptives containing desogestrel were associated with more adverse effects on serum lipids and blood pressure compared to those containing drospirenone in patients with polycystic ovary syndrome.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on sjku.muk.ac.ir →
    Discuss this study in the Community →

    Research cited in this study 7

    1. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1 Endocrine Practice · 2015
    2. Treatment Options for Polycystic Ovary Syndrome International journal of women's health · 2011
    3. Use of Ethinylestradiol/Drospirenone Combination in Patients with Polycystic Ovary Syndrome Therapeutics and clinical risk management · 2008
    4. Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline The Journal of Clinical Endocrinology and Metabolism · 2006
    5. Progestogens With Antiandrogenic Properties Drugs · 2003
    6. The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders ˜The œAmerican journal of medicine · 1995
    7. Classification of the Types of Androgenetic Alopecia (Common Baldness) Occurring in the Female Sex British Journal of Dermatology · 1977